ING Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-40,000
Closed -$2.35M 639
2023
Q4
$2.35M Buy
+40,000
New +$2.35M 0.02% 389